Senior insider sale
Chief Financial Officer at VERA THERAPEUTICS, INC. — senior position signals high conviction
$4.68M
118.48K shares
What this filing means
GRANT SEAN plans to sell 118.48K shares of VERA THERAPEUTICS, INC. valued at approximately $4.68M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/3/2024ACC: 0001974078-24-000148
Officer· Chief Financial Officer
Since Jul 2021
118.48K
Shares to sell
$4.68M
Approx. market value
118.48K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months7
Purchase
Cash
2/2/2023
1.62KPurchase
cash
2/2/2023
12.66KPurchase
cash
6/15/2022
356.00Purchase
Cash
6/15/2022
2.82KPurchase
Cash
6/15/2022
335.00Purchase
cash
6/15/2022
857.00In lieu of services/compensation
N/A
7/31/2021
99.83KTotal acquired118.48K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/2/2023 | Purchase Cash | 1.62K | — |
2/2/2023 | Purchase cash | 12.66K | — |
6/15/2022 | Purchase cash | 356.00 | — |
6/15/2022 | Purchase Cash | 2.82K | — |
6/15/2022 | Purchase Cash | 335.00 | — |
6/15/2022 | Purchase cash | 857.00 | — |
7/31/2021 | In lieu of services/compensation N/A | 99.83K | — |
| Total | 118.48K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
118.48K
Market value
$4.68M
4/3/2024
Total
Units
118.48K
Value
$4.68M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/3/2024 | 118.48K | $4.68M | Nasdaq | Planned |
| Total | 118.48K | $4.68M | ||